Tilray Brands(NASDAQ) TLRY

Market Cap$549.75MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-98%
5 Year-97%
1 Year-77%
1 Month-17%
Premium Feature
Moneyball Superscore
35/100
$3.72
+2.91%
+0.11Today
After hours$3.75+$0.03 (+0.94%)
Tilray Brands last closing stock price
MetricPriceDate
Last closeUSD 3.722026-10-05
Tilray Brands stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-7.46%USD 4.022026-09-28
1 month-17.33%USD 4.502026-09-04
3 month-13.69%USD 4.312026-07-07
Year to date-58.8%USD 9.032025-12-31
1 year-77.04%USD 16.202025-10-03
3 year-81.94%USD 20.602023-10-06
5 year-96.55%USD 107.902021-10-06
Since inception-97.69%USD 161.002021-05-04

Tilray Brands Financials at a Glance

Market Cap

$549.75MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$915.45

Net Income (TTM)

-$105.16

EPS (TTM)

-$1.08

P/E Ratio

-3.46

Dividend

$0.00

Beta (Volatility)

1.73 (High)

Price

$3.72

Volume

29,429.336

Open

$3.65

Previous Close

$3.72

Daily Range

$3.61 - $3.79

52-Week Range

$3.54 - $23.20

Estimated Earnings Date

N/A

About Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Industry

Pharmaceuticals

Employees

3,595

CEO

Irwin David Simon

TLRY Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

-7.77%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-28.90%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$549.75MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

147.78M

Volume

29.43K

Avg. Volume

4.09M

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Tilray Brands Performance Analysis

Tilray Brands annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-05-31USD 627,124,000-0.2%
20242024-05-31USD 788,942,00025.8%
20252025-05-31USD 821,309,0004.1%
20262026-05-31USD 915,454,00011.5%
Tilray Brands annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-05-31USD -23.51137.2%
20242024-05-31USD -3.30-86.0%
20252025-05-31USD -24.56644.6%
20262026-05-31USD -1.09-95.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$281.71

+1.3%

Gross Profit

$84.33

+1.8%

Gross Margin

29.93%

+1.4%

Market Cap

$549.75MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$0.18

N/A

Employees

3,595

N/A

Net Income

-$37.93

+0.0%

EBITDA

$14.83

+0.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$627.74

+14.1%

Total Debt

$398.40

+1.2%

Accounts Receivable

$189.17

+1.6%

Inventory

$301.19

+1.1%

Long Term Debt

$358.11

+1.2%

Short Term Debt

$40.29

+1.4%

Return on Assets

-5.43%

+0.1%

Return on Invested Capital

-36.64%

+1.8%

Free Cash Flow

-$47.66

+2.3%

Operating Cash Flow

-$37.47

+2.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,777.74+0.01%
^DJIDJI
$51,304.21+0.00%
^IXICNASDAQ
$27,461.27+0.01%
BTCBitcoin
$85,510.00+0.00%

Questions About TLRY

What is the current price of Tilray Brands?

Tilray Brands is trading at $3.72 per share.

What is the 52-week range for Tilray Brands?

Over the past 52 weeks, Tilray Brands has traded between $3.54 and $23.20.

How much debt does Tilray Brands have?

As of the most recent reporting period, Tilray Brands reported total debt of $398.40M.

How much cash does Tilray Brands have on hand?

Tilray Brands reported $229.34M in cash and cash equivalents in its most recent financial results.

What is Tilray Brands’s dividend yield?

Tilray Brands does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.